Answers are grounded in this paper and cite their sources.
Creutzfeldt-Jakob disease (CJD) is a rare, rapidly progressive, and universally fatal neurodegenerative disease. Beyond its diagnostic and prognostic challenges, CJD presents profound ethical dilemmas when patients lack the capacity to participate in medical decisions. This case presents a middle-aged patient with paranoid schizophrenia, recent incarceration, and complex psychosocial determinants of health who was admitted for subacute progressive encephalopathy after being found down during a wellness check and had no contact with his family for decades, lacked an advance directive or identifiable surrogate, and was judged to lack decision-making capacity. The hospital course was complicated by incidental findings of acute pulmonary embolism and a rapid neurological decline which was later revealed to have a high likelihood of prion disease. We present the interdisciplinary process in diagnosing and developing a treatment plan that best reflects the patient's values and goals of care. This case also highlights essential considerations for clinical practice when caring for an unrepresented patient with irreversible loss of decision-making capacity at the end of life, including the application of ethical principles, adherence to institutional policies and legal frameworks, and the implementation of a patient-centered approach that preserves dignity, promotes comfort, and protects vulnerable individuals.
No takes yet. Share an insight, caveat, or question.
Cheng et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: